(Q33375021)

26 July 2017

title

Severe anaphylactic reaction after repeated intermittent exposure to lepirudin (English)

1 reference

26 July 2017

1 reference

Sidney A Veach

1

1 reference

26 July 2017

Amy M Franks

series ordinal

2

1 reference

26 July 2017

Michael C Allan

series ordinal

3

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

26 July 2017

1 reference

26 July 2017

volume

27

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

760-765

1 reference

Treatment of heparin-induced thrombocytopenia

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

Temporal aspects of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

Acute urticaria caused by subcutaneous recombinant hirudin: evidence for an IgG-mediated hypersensitivity reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

Treatment of an acute flush reaction caused by subcutaneous r-hirudin with pegylated hirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

Re-exposure to recombinant (r)-hirudin in antihirudin antibody-positive patients with a history of heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.760

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.5.760

1 reference

26 July 2017

1 reference